viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
uurimisrühmad - University of Tennessee, College of Pharmacy
University of Tennessee, College of Pharmacy
Memphis
halmoaze@uthsc.edu
Viited
(4)
1
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. (tsweatman@utmem.edu)
J Pediatr Pharmacol Ther -
2004
- ; 9, 2: 126-132.
2
Stability of ondansetron hydrochloride in syrups compounded from tablets
Williams CL, Sanders PL, Laizure SC, Stevens RC, Fox JL, Hak LJ. ()
Am J Hosp Pharm -
1994
- ; 51: 806-809.
3
Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection.
Stewart CF, Fleming RA. ()
Am J Hosp Pharm -
1990
- ; 47: 1373-1377.
4
Stability of cisplatin and etoposide in intravenous admixtures.
Stewart CF, Hampton EM. ()
Am J Hosp Pharm -
1989
- ; 46: 1400-1404.
molekulid uuritud
(18)
Atracurium besylate
Cisplatin
Dexamethasone sodium phosphate
Diazepam
Etoposide
Fluorouracil
Fosphenytoin sodium
Lorazepam
Magnesium sulfate
Mannitol
Methylprednisolone sodium succinate
Midazolam hydrochloride
Ondansetron hydrochloride
Pentobarbital sodium
Phenytoin sodium
Ranitidine hydrochloride
Thiopental sodium
Valproic acid
Mentions Légales
